These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary? Chaugule SS; Park J; Finger PT Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b. Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia. Bahrami B; Greenwell T; Muecke JS Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413 [TBL] [Abstract][Full Text] [Related]
6. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study. Blasi MA; Maceroni M; Sammarco MG; Pagliara MM Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia. Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301 [TBL] [Abstract][Full Text] [Related]
8. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578 [TBL] [Abstract][Full Text] [Related]
9. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia. Kusumesh R; Ambastha A; Sinha B; Kumar R Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194 [TBL] [Abstract][Full Text] [Related]
15. Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea. Yeatts RP; Ford JG; Stanton CA; Reed JW Ophthalmology; 1995 Sep; 102(9):1338-44. PubMed ID: 9097771 [TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Yeatts RP; Engelbrecht NE; Curry CD; Ford JG; Walter KA Ophthalmology; 2000 Dec; 107(12):2190-5. PubMed ID: 11097594 [TBL] [Abstract][Full Text] [Related]
17. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208 [TBL] [Abstract][Full Text] [Related]
18. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C. Nemet AY; Sharma V; Benger R Clin Exp Ophthalmol; 2006; 34(4):375-7. PubMed ID: 16764660 [TBL] [Abstract][Full Text] [Related]
19. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment. Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390 [TBL] [Abstract][Full Text] [Related]
20. Ocular surface squamous neoplasia: a standard of care survey. Stone DU; Butt AL; Chodosh J Cornea; 2005 Apr; 24(3):297-300. PubMed ID: 15778602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]